173 related articles for article (PubMed ID: 8675656)
1. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).
Brennan SO; Hammonds B; George PM
J Clin Invest; 1995 Dec; 96(6):2854-8. PubMed ID: 8675656
[TBL] [Abstract][Full Text] [Related]
2. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.
Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925
[TBL] [Abstract][Full Text] [Related]
7. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
[TBL] [Abstract][Full Text] [Related]
9. Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates.
Lord ST; Strickland E; Jayjock E
Biochemistry; 1996 Feb; 35(7):2342-8. PubMed ID: 8652575
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G
Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644
[TBL] [Abstract][Full Text] [Related]
11. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Rooney MM; Mullin JL; Lord ST
Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity.
Ni F; Zhu Y; Scheraga HA
J Mol Biol; 1995 Oct; 252(5):656-71. PubMed ID: 7563081
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen.
Seydewitz HH; Gram J; Bruhn HD; Witt I
Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen New Britain: characterization of an A alpha Arg 16-->His variant human fibrinogen.
Webb CD; Hantgan RR; Byeff PD; Owen J
Blood Coagul Fibrinolysis; 1994 Apr; 5(2):233-8. PubMed ID: 8054455
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S
Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: fibrinogen Mannheim V.
Dempfle CE; George PM; Borggrefe M; Neumaier M; Brennan SO
Thromb Haemost; 2009 Jul; 102(1):29-34. PubMed ID: 19572064
[TBL] [Abstract][Full Text] [Related]
17. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
[TBL] [Abstract][Full Text] [Related]
18. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
Furlan M; Leupin L; Biasiutti FD; Lämmle B
Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
Bolliger-Stucki B; Lord ST; Furlan M
Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303
[TBL] [Abstract][Full Text] [Related]
20. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin.
Maurer MC; Peng JL; An SS; Trosset JY; Henschen-Edman A; Scheraga HA
Biochemistry; 1998 Apr; 37(17):5888-902. PubMed ID: 9558322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]